Tirbanibulin: FDA-Approved Breakthrough for Actinic Keratosis Treatment

Tirbanibulin: FDA-Approved Breakthrough for Actinic Keratosis Treatment

(Dr HA) FDA Approves Klisyri (Tirbanibulin) for Actinic Keratosis / Bs Võ Hoàng AnhПодробнее

(Dr HA) FDA Approves Klisyri (Tirbanibulin) for Actinic Keratosis / Bs Võ Hoàng Anh

Buffalo-formed company Athenex gets FDA approval for cancer drugПодробнее

Buffalo-formed company Athenex gets FDA approval for cancer drug

Pre-Cancers or Actinic Keratosis Treatment Options With Dr. Timothy JochenПодробнее

Pre-Cancers or Actinic Keratosis Treatment Options With Dr. Timothy Jochen

Photodynamic Therapy - The effective treatment for Actinic KeratosisПодробнее

Photodynamic Therapy - The effective treatment for Actinic Keratosis

Actinic Keratosis Mode of Action AnimationПодробнее

Actinic Keratosis Mode of Action Animation

Dr. Sherry Ingraham of Advanced Dermatology Speaks About Actinic Keratoses TreatmentsПодробнее

Dr. Sherry Ingraham of Advanced Dermatology Speaks About Actinic Keratoses Treatments

Fox 9 News - First Ever FDA-approved Drug for Vitiligo w/ Dr. TareenПодробнее

Fox 9 News - First Ever FDA-approved Drug for Vitiligo w/ Dr. Tareen

FDA approves treatment for teen with rare diseaseПодробнее

FDA approves treatment for teen with rare disease

Actinic keratosis removal, treatments, and prevention| Dr DrayПодробнее

Actinic keratosis removal, treatments, and prevention| Dr Dray

Tafinlar Approved for Advanced Skin CancerПодробнее

Tafinlar Approved for Advanced Skin Cancer

FDA Approves IbranceПодробнее

FDA Approves Ibrance

Regulatory Update: Three FDA Approvals and Two Priority ReviewsПодробнее

Regulatory Update: Three FDA Approvals and Two Priority Reviews

Managing extravasationПодробнее

Managing extravasation

FDA D.I.S.C.O. Burst Edition: FDA approval of Verzenio (abemaciclib) with endocrine therapy for p...Подробнее

FDA D.I.S.C.O. Burst Edition: FDA approval of Verzenio (abemaciclib) with endocrine therapy for p...

Is Finite-Duration Therapy the New Frontline Standard of Care for CLL?Подробнее

Is Finite-Duration Therapy the New Frontline Standard of Care for CLL?

Comparing midostaurin to next-generation FLT3 inhibitors in the frontline treatment of FLT3-ITD AMLПодробнее

Comparing midostaurin to next-generation FLT3 inhibitors in the frontline treatment of FLT3-ITD AML

Fedratinib in MF: JAKARTA2 and FREEDOM TrialsПодробнее

Fedratinib in MF: JAKARTA2 and FREEDOM Trials

Актуальное